NIH Moves Non-Animal Testing Toward the Institutional Core, as ORIVA Faces Tests of Validation and Trust
The new office means organoids, human tissue models, and AI simulations are no longer just marginal experiments among alternatives; the real challenge is turning them into a shared language that research funding, drug review, and safety assessment are all willing to accept.